Oflaect 15, 30 & 60 Injection 15 mg, 20 mg, 60 mg Injection
PDF Leaflet Revision Date: 08 August 2023
Clinical Summary
Quick overview from the medicine insert
Indication
Short-term management of moderate post-operative pain.
Dosage (summary)
Adults: IM/IV 10-60 mg; max 90 mg/day (<65 years), 60 mg/day (u226565 years, renal impairment).
Onset of Action / Duration
Onset: 30 mins, Duration: 4-6 hours
Special Populations
- Elderly
- Renal impairment
Pregnancy & Breastfeeding
Contraindicated in pregnancy and lactation; may impair fertility.
Key Drug Interactions
- Increased bleeding risk with anticoagulants
- Avoid with other NSAIDs
Contraindications
- Hypersensitivity to ketorolac
- Active peptic ulcer disease
- Severe renal impairment
- Pregnancy
Common side effects
- Drowsiness
- Nausea
- Hypertension
- Gastrointestinal pain
Counselling Points
- Use lowest effective dose for shortest duration
- Monitor for signs of gastrointestinal bleeding
- Avoid alcohol
Serious warnings
- Serious gastrointestinal toxicity risk
- Anaphylactic reactions possible
Important Disclaimer
The Oflaect 15, 30 & 60 Injection 15 mg, 20 mg, 60 mg Injection professional information leaflet below is the property of Hetero Drugs South Africa and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
